Sustained-release methylphenidate for cognitive impairment in HIV-1-infected drug abusers: A pilot study

Journal of Neuropsychiatry and Clinical Neurosciences

Volumn 9, Issue 1, 1997, Pages 29-36

  Van Dyck, Christopher H ^a   McMahon, Thomas J ^a   Rosen, Marc I ^a   O'Malley, Stephanie S ^a   O'Connor, Patrick G ^a   Lin, C Huie ^a   Pearsall, H Rowland ^a   Woods, Scott W ^a   Kosten, Thomas R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOMANIA; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE FORMULATION;

EID: 0031028945     PISSN: 08950172     EISSN: None     Source Type: Journal    
DOI: 10.1176/jnp.9.1.29     Document Type: Article

References (44)

1. Egan V, Brettle RP, Goodwin CM: The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatry 1992; 161:522-531
2. McKegney FP, O'Dowd MA, Feiner C, et al: A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1990; 4:565-569
3. Grant I, Atkinson JH, Hesselink JR, et al: Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Ann Intern Med 1987; 107:828-836
4. Miller EN, Selnes OA, McArthur JC, et al: Neuropsychological performance in HIV-1-infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology 1990; 40:197-203
5. Jacobvitz D, Sroufe LA, Stewart M, et al: Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiatry 1990; 29:677-688
6. Lipper S, Tuchman MM: Treatment of chronic post-traumatic organic brain syndrome with dextroamphetamine: first reported case. J Nerv Ment Dis 1976; 162:366-371
7. Crook T, Ferris S, Sathananthan G, et al: The effect of methylphenidate on test performance in the cognitively impaired aged. Psychopharmacology 1977; 52:251-255
8. Naylor H, Halliday R, Callaway E: The effect of methylphenidate on information processing. Psychopharmacology 1985; 86:90-95
9. Strauss J, Lewis JL, Klorman R, et al: Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test. Psychophysiology 1984; 21:609-621
10. Fernandez F, Adams F, Levy JK, et al: Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 1988; 9:38-46
11. Angrist B, d'Hollosy M, Sanfilipo M, et al: Central nervous system stimulants as symptomatic treatments for AIDS-related neuropsychiatric impairment. J Clin Psychopharmacol 1992; 12:268-272
12. Craven DE, Liebman HA, Fuller J, et al: AIDS in intravenous drug users: issues related to enrollment in clinical trials. J Acquir Immune Defic Syndr 1990; 3:S45-S50
13. Crowley TJ: Cautionary note on methylphenidate for cocaine dependence. Am J Psychiatry 1984; 141:327-328
14. Gawin F, Riordan C, Kleber H: Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse 1985; 11:193-197
15. Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R: outpatient version (SCID-OP, 4/1/87). New York, Biometrics Research Department, New York State Psychiatric Institute, 1987
16. Schmitt FA, Bigley JW, McKinnis R, et al: Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988; 319:1573-1578
17. Karlsen NR, Reinvang I, Froland SS: A follow-up study of neuropsychological functioning in AIDS patients: prognostic significance and effect of zidovudine therapy. Acta Neurol Scand 1995; 91:215-221
18. Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993; 41:1-19
19. Wechsler D: Wechsler Adult Intelligence Scale-Revised. New York, Psychological Corporation, 1981
20. Dunn LM, Markwardt FC: PIAT: Peabody Individual Achievement Test. Circle Pines, MN, American Guidance Service, 1970
21. Levin HS, Mattis S, Ruff RM, et al: Neurobehavioral outcome following minor head injury: a three-center study. J Neurosurgery 1987; 66:234-243
22. Roman DD, Edwall GE, Buchanan RJ, et al: Extended norms for the Paced Auditory Serial Addition Task. Clin Neuropsychologist 1991; 5:33-40
23. Heaton RK, Grant I, Matthews CG: Comprehensive Norms for an Extended Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, FL, Psychological Assessment Resources, 1991
24. Lewis RF, Rennick PM: Manual for the Repeatable Cognitive-Per-ceptual-Motor Battery. Grosse Pointe Park, MI, Axon Publishing, 1979
25. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, AZ, Neuropsychology Press, 1985
26. Lezak MD: Neuropsychological Assessment. New York, Oxford University Press, 1983
27. Instructions for the Grooved Pegboard Test. Lafayette, IN, Lafayette Instrument Company, 1989
28. Benton AL, Hamsher KD: Multilingual Aphasia Examination, 2nd edition. Iowa City, IA, University of Iowa, 1976
29. Yeudall LT, Fromm D, Reddon JR, et al: Normative data stratified by age and sex for 12 neuropsychological tests. J Consult Clin Psychol 1986; 42:918-946
30. Parker ES, Bridge T, Ingraham L, et al: Neurotoxicity battery for phase I HIV drug assessment: initial applications (abstract). International Conference on AIDS 1989; 5(2):462
31. Bridge TP, Heseltine PN, Parker ES: Improvement in AIDS patients on peptide T. Lancet 1989; 1:226-227
32. Rosen MI, Bridge TP, O'Malley SS, et al: Peptide T treatment of cognitive impairment in HIV seropositive intravenous drug users. American Journal on Addictions 1992; 1:1-7
33. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
34. Hamilton M: The assessment of anxiety by rating. Br J Med Psychol 1959; 32:50-55
35. Hathaway SR, McKinley JC: Minnesota Multiphasic Personality Inventory: Manual for Administration and Scoring. Minneapolis, MN, University of Minnesota Press, 1983
36. Derogatis LC, Lipman RS, Cori L: SCL-90: an outpatient psychiatric rating scale: preliminary report. Psychopharmacol Bull 1973; 9:13-25
37. Girden ER: ANOVA: Repeated Measures. Newbury Park, CA, Sage, 1992
38. Hills M, Armitage P: The two-period cross-over clinical trial. Br J Clin Pharmacol 1979; 8:7-20
39. Barkley RA, DuPaul GJ, Costello A: Stimulants, in Practitioners Guide to Psychoactive Drugs for Children and Adolescents, edited by Werry JS, Aman MG. New York, Plenum Medical, 1993, pp 205-237
40. Kuczenski R, Segal D: Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J Neurosci 1989; 9:2051-2065
41. Fernandez F, Levy JK, Galizzi H: Response of HIV-related depression to psychostimulants: case reports. Hosp Community Psychiatry 1988; 39:628-631
42. Holmes VF, Fernandez F, Levy JK: Psychostimulant response in AIDS-related complex patients. J Clin Psychiatry 1989; 50:5-8
43. White JC, Christensen JF, Singer CM: Methylphenidate as a treatment for depression in acquired immunodeficiency syndrome: an n-of-1 trial. J Clin Psychiatry 1992; 53:153-156
44. Grant I, Olshen RA, Atkinson JH, et al: Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology 1993; 7:53-61